BioSpace News Archive

Phillips-Medisize, a Molex company, announced the appointment of Paul Chaffin as Senior Vice President and President of the Medical and Pharmaceutical Solutions division of Molex.

Risk stratification tool designed to help reduce burden on hospitals by helping surgeons transition more total joint arthroplasty cases to outpatient or same-day discharge

Stellar Health, a rapidly growing value-based healthcare technology company headquartered in New York City, announced today that it has raised over $10 million in Series A funding.

Orange County-based LifePharm® is proud to announce their revolutionary skin care serum Lamiderm Apex® has been granted a Gold Quality Award from the prestigious Monde Selection!

Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the publication of a driving study which demonstrates the tolerability and safety of tolperisone in the peer-reviewed Journal of Clinical Pharmacy and Therapeutics . The publication, “An assessment

Amitech Solutions, a leading healthcare data, analytics and automation consulting firm, announces the launch of a new suite of robotic process automation solutions for healthcare.

Jeanne Magram, Ph.D., Appointed to Chief Scientific Officer Ren é Russo, Pharm.D., Joins Board of Directors CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Celsius Therapeutics, a company focused on bringing precision medicine to patients with cancer, autoimmunity and other complex diseases, today announced the appointment of Jeanne Magram, Ph.D., to chief scientific officer. Christoph Lengauer, Ph.D., a partner at Third Rock Ventures and co-founder and

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that Dr. Andrew Brenner, development leader of an innovative drug portfolio platform that the company has recently licensed, is scheduled to conduct a live patient-focused webinar entitled, “A Promising New Radiotherapy for Recurrent Glioblastoma: An Introduction”, on Sunday, May 17, 2020, at 7 pm EDT.

Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference at 1:40 p.m. ET on Thursday , May 14. Peter H. Griffith , executive vice president and chief financial officer, and Murdo Gordon , executive vice president of Global Commercial Operations at Amgen will present. Live

Travecta Therapeutics, a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain-barrier, announces today it has secured US$15 million in its Series A round of financing, led by TKS1, a life science focused venture capital fund formed by the partnership between SPRIM